Abstract:BackgroundSystemic immune activation (inflammation) and immunosenescence develop in some people with advancing age. This process, known as “inflamm-aging,” is associated with physical frailty and sarcopenia. Meanwhile, successful antiretroviral therapy has led to a growing number of older HIV-1-infected individuals who face both age-related and HIV-1-related inflammation, which may synergistically promote physical decline, including frailty and sarcopenia. The purpose of our study was to determine if inflammation during treated HIV-1 infection worsens physical impairment in older individuals.MethodsWe determined the severity of HIV-associated inflammation and physical performance (strength and endurance) in 21 older HIV-infected individuals (54–69 years) receiving suppressive antiretroviral therapy, balanced for confounding variables including age, anthropometrics, and co-morbidities with 10 uninfected control individuals. Biomarkers for microbial translocation (lipopolysaccharide [LPS]), inflammation (soluble CD14 [sCD14], osteopontin, C-reactive protein [CRP], interleukin-6 [IL-6], soluble ICAM-1 [sICAM-1] and soluble VCAM-1 [sVCAM-1]), and coagulopathy (D-dimer) were assayed in plasma. Activation phenotypes of CD4+T cells, CD8+ T cells and monocytes were measured by flow cytometry. Physical performance was measured by 400 m walking speed, a short physical performance battery [SPPB], and lower extremity muscle strength and fatigue.ResultsOverall physical function was similar in the uninfected and HIV-infected groups. Compared to uninfected individuals, the HIV-infected group had elevated levels of sCD14 (P < 0.001), CRP (P < 0.001) and IL-6 (P = 0.003) and an increased frequency of CD4+ and CD8+ T cells with an immunosenescent CD57+ phenotype (P = 0.004 and P = 0.043, respectively). Neither plasma inflammatory biomarkers nor CD57+ T cells correlated with CD4+ T cell counts. Furthermore, none of the elevated inflammatory biomarkers in the HIV-infected subjects were associated with any of the physical performance results.ConclusionsWhen age-related co-morbidities were carefully balanced between the uninfected and HIV-infected groups, no evidence of inflammation-associated physical impairment was detected. Despite careful balancing for age, BMI, medications and co-morbidities, the HIV-infected group still displayed evidence of significant chronic inflammation, including elevated sCD14, CRP, IL-6 and CD57+ T cells, although the magnitude of this inflammation was unrelated to physical impairment.

Reduced Levels of NAD in Skeletal Muscle and Increased Physiologic Frailty Are Associated With Viral Coinfection in Asymptomatic Middle-Aged Adults

Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus

Unveiling the Nexus of CD38 Overactivation, NAD+ Depletion, and Mitochondrial Dysfunction in Immunological Failure Among Virologically Suppressed HIV Patients

Reduced heart rate variability is associated with altered clinical laboratory profile in people living with HIV

Biomarkers of microbial translocation and generalized inflammation are associated with frailty among people with HIV

Comprehensive Metabolomics Profiling Reveals Common Metabolic Alterations Underlying the Four Major Non-Communicable Diseases in Treated HIV Infection

Factors associated with skeletal muscle mass in middle‐aged men living with HIV

Relationships Between Hepatic Steatosis and Frailty Differ by HIV Serostatus

Muscle Quality and Physical Function in Men With and Without HIV

Accelerated Aging process in Patients Living with HIV: Role of Mitochondrial Dysfunction.

Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects

A Unique Gut Microbiome-Physical Function Axis Exists In Older People With HIV: An Exploratory Study.

Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIV

Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice

Associations Between HIV Infection and Frailty Status and Its Individual Components: Are Frailty Components Disproportionally Affected?

Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection

Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV

Correction: Interaction of Declined Handgrip Strength and HIV Infection on Neurocognitive Impairment

NAD deficiency contributes to progressive kidney disease in HIV nephropathy mice

Cardiac MRI‐Based Assessment of Myocardial Injury in Asymptomatic People Living With Human Immunodeficiency Virus: Correlation With nadir CD4 Count

Relationships between plasma neurofilament light chain protein, cognition, and brain aging in people with HIV